Fundamentals

IPCA LABORATORIES

Ticker : 524494
BUY: Rs. 972.80
Target: Rs. 1075



IPCA Laboratories Ltd is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. It is one of the world's largest manufacturers and suppliers of over a dozen APIs. On the consolidated financial front, the company reported its revenues for Q4FY19 at Rs 833.81 crore, up by 6.69 per cent from Rs 781.56 crore posted in Q4FY18. The PBIDT grew by 60.69 per cent to Rs 174.67 crore in Q4FY19 as against Rs 108.7 crore posted in the same quarter of the previous year. The PAT in Q4FY19 and was reported at Rs 444.03 crore from Rs 96.20 crore reported in Q4FY18 thus expressing a growth of 259 per cent. The ROE was 15.28 per cent and the RoCE was 16.53 per cent. We recommend a BUY looking at the healthy financials.